Newsfeeds - Spark Newswire

1 minute read

BriaCell Therapeutics Shares Spike To Session High Following Seeking Alpha Blogpost From Contributor ‘AAA Investments’ ‘Why BCTX Is Undervalued – PT $30+’

By Benzinga Newsdesk

Today, 5:15 AM

https://seekingalpha.com/instablog/55419735-aaa-investments/5669359-why-bctx-is-undervalued-pt-30-plus

BCTX

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:15 AM

Gainers

ANY

1 minute read

From BZ’s Small Cap Healthcare Conference: BriCell President, Director & CEO, William V. Williams Begins Speaking

By Zoltan Suranyi

Today, 5:15 AM

Click To Tune In Here... https://www.youtube.com/watch?v=KS30Mcu5ei8

BCTX

7 minute read

The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

By Shanthi Rexaline

Today, 5:15 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28)

ABBV

3 minute read

BriaCell’s Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer

By Mark Gilman

Today, 5:15 AM

Photo by Artem Podrez from Pexels

BCTX

3 minute read

Briacell’s Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer

By Mark Gilman

Today, 5:15 AM

Photo by Artem Podrez from Pexels

BCTX

1 minute read

BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial

By Vandana Singh

Today, 5:15 AM

BriaCell Therapeutics Corp (NASDAQ:BCTX) has announced a multi-year, non-exclusive license agreement with ImaginAb Inc for developing next-generation immuno-oncology imaging agents and radiopharmaceutical therapies.…

BCTX

2 minute read

News

BriaCell and ImaginAb Announce Collaboration To Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer

By Benzinga Newsdesk

Today, 5:15 AM

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW)) (TSXV:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast

BCTX